[1]
|
Akiyama, H., Barger, S., et al. (2010) Inflammation in Alzheimer’s disease. Neurobiology of Aging, 21, 383-421.
doi:10.1016/S0197-4580(00)00124-X
|
[2]
|
Remarque, E.J., Bollen, E.L., Weverling-Rijnsburger, A.W., Laterveer, J.C., Blauw, G.J. and Westendorp, R.G.J. (2001) Patients with Alzheimer’s disease display a pro-inflammatory phenotype. Experimental Gerontology, 36, 171-176. doi:10.1016/S0531-5565(00)00176-5
|
[3]
|
Nelson, P.T., Somam, L.A. and Lavi, E. (2002) Microglia in diseases of the central nervous system. Annals of Medicine, 34, 491-500.
doi:10.1080/078538902321117698
|
[4]
|
Hauss-Wegrzyniak, B., Vraniak, P. and Wenk, G.L. (1999) The effects of a novel NSAID upon chronic neuroinflammation are age dependent. Neurobiology of Aging, 20, 305-313. doi:10.1016/S0197-4580(99)00028-7
|
[5]
|
Imbimbo, B.P. (2009) An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer’s disease. Expert Opinion on Investigational Drugs, 18, 1147-1168.
doi:10.1517/13543780903066780
|
[6]
|
Marchalant, Y., Rosi, S. and Wenk, G.L. (2007) Anti-inflammatory property of the cannabinoid agonist WIN- 55212-2 in a rodent model of chronic brain inflammation. Neuroscience, 144, 1516-1522.
doi:10.1016/j.neuroscience.2006.11.016
|
[7]
|
Marchalant, Y., Cerbai, F., Brothers, H.M. and Wenk, G.L. (2008) Cannabinoid receptor stimulation is anti-inflamematory and improves memory in old rats. Neurobiology of Aging, 29, 1894-1901.
doi:10.1016/j.neurobiolaging.2007.04.028
|
[8]
|
Marchalant, Y., Brothers, H.M. and Wenk, G.L. (2008) Inflammation and aging, can endocannabinoids help? Biomedical Pharmacotherapy, 6, 212-217.
doi:10.1016/j.biopha.2008.02.004
|
[9]
|
Marchalant, Y., Brothers, H.M. and Wenk, G.L. (2009) Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain. Molecular Psychiatry, 14, 1068-1071. doi:10.1038/mp.2009.62
|
[10]
|
Willard, L.B., Hauss-Wegrzyniak, B., Danysz, W. and Wenk, G.L. (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenage-2 inhibition. Experimental Brain Research, 134, 58-65. doi:10.1007/s002210000446
|
[11]
|
Rosi, S., Ramirez-Amaya, V., Vazdarjanova, A., Worley, P.F., Barnes, C.A. and Wenk, G.L. (2005) Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. Journal of Neuroscience, 25, 723-731. doi:10.1523/JNEUROSCI.4469-04.2005
|
[12]
|
Rosi, S., Vaz-darjanova, A., Ramirez-Amaya, V., Worley, P.F., Barnes, C.A. and Wenk, G.L. (2006) Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience, 142, 1303-1315.
doi:10.1016/j.neuroscience.2006.08.017
|
[13]
|
Di Marzo, V., Melck, D., Bisogno, T. and De Petrocellis, L. (1998) Endocan-nabinoids, endogenous cannabinoid receptor ligands with neuromodulatory action. Trends in Neurosciences, 21, 521-528.
doi:10.1016/S0166-2236(98)01283-1
|
[14]
|
Cabral, G.A. and Griffin-Thomas, L. (2008) Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocrine Metabolism, Immune Disorders & Drug Targets, 8, 159-172.
doi:10.2174/187153008785700118
|
[15]
|
Piomelli, D. (2003) The molecular logic of endocannabinoid signaling. Nature Reviews Neuroscience, 4, 873-884.
doi:10.1038/nrn1247
|
[16]
|
Alger, B.E. and Kim, J. (2011) Supply and demand for endocannabinoids. Trends in Neurosciences, 34, 6-10.
doi:10.1016/j.tins.2011.03.003
|
[17]
|
Pertwee, R.G. (2005) Pharmacological actions of cannabinoids. Handbook of Experimental Pharmacology, 168, 1-51. doi:10.1007/3-540-26573-2_1
|
[18]
|
Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M. and Tarzia, G. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3’- carbamoyl-biphenyl-3-yl ester (URB597), effects on anandamide and oleoylethanolamide deactivation. Journal of Pharmacology & Experimental Therapeutics, 313, 352-358. doi:10.1124/jpet.104.078980
|
[19]
|
Hwang, J., Adamson, C., Butler, D., Janero, D.R., Makriyannis, A. and Bahr, B.A. (2010) Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition, a neuroprotective therapeutic modality. Life Sciences, 86, 615-623. doi:10.1016/j.lfs.2009.06.003
|
[20]
|
Ortega-Gutierrez, S., Molina-Holgado, E. and Guaza, C. (2005) Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia, 52, 163-168.
doi:10.1002/glia.20229
|
[21]
|
Loría, F., Petrosino, S., et al. (2010) An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Neurobiology of Disease, 37, 736-749.
|
[22]
|
Rogawski, M. and Wenk, G.L. (2003) The neuropharmacological basis for Memantine in the treatment of Alzheimer’s disease. CNS Drug Review, 9, 275-308.
doi:10.1111/j.1527-3458.2003.tb00254.x
|
[23]
|
Astarita, G. and Piomelli, D. (2009) Lipidomic analysis of endocannabinoid metabolism in biological samples. Journal of Chromatography B, 877, 2755-2767.
doi:10.1016/j.jchromb.2009.01.008
|
[24]
|
Giuffrida, A., Rodriguez de Fonseca, F., Nava, F. and Loubet-Lescoulie, P. (2000) Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. European Journal of Pharmacology, 408, 161- 168. doi:10.1016/S0014-2999(00)00786-X
|
[25]
|
Eisenstein, S.A., Holmes, P.V. and Hohmann, A.G. (2009) Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation. Synapse, 63, 941-950.
doi:10.1002/syn.20679
|
[26]
|
Haller, J., Barna, I., et al. (2009) Interactions between environmental aversiveness and the anxi-olytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology, 204, 607-616.
doi:10.1007/s00213-009-1494-7
|
[27]
|
Ahn, K., Johnson, D.S., et al. (2007) Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry, 46, 13019-13030.
doi:10.1021/bi701378g
|
[28]
|
Marchalant, Y., Brothers, H.M., Norman, G.J., Karolina, K., De Vries, C. and Wenk, G.L. (2009) Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiology of Disease, 34, 300-307.
doi:10.1016/j.nbd.2009.01.014
|
[29]
|
Stella, N. (2009) Endocannabinoid signaling in microglia cells. Neuropharmacology, 56, 244-253.
doi:10.1016/j.neuropharm.2008.07.037
|
[30]
|
Jiang, X., Newell, E.W. and Schlichter, L.C. (2003) Regulation of TRPM7-like current in rat brain microglia. Journal of Biological Chemistry, 278, 42867-42876.
doi:10.1074/jbc.M304487200
|